Eloxx Pharmaceuticals, Inc.

Biotechnology company · Arlington, Massachusetts, United States · Nasdaq: ELOX

Eloxx Pharmaceuticals, Inc. is a biotechnology company headquartered in Arlington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker ELOX. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2015.

Profile compiled from public records. Is this your company? Request a correction or update

Eloxx Pharmaceuticals at a glance

Typebiotechnology company
HeadquartersArlington, Massachusetts, United States
Stock listingNasdaq: ELOX
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1035354

What does Eloxx Pharmaceuticals do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $3 million sold (2015).

Frequently asked questions about Eloxx Pharmaceuticals

Where is Eloxx Pharmaceuticals headquartered?

Eloxx Pharmaceuticals, Inc. is headquartered in Arlington, Massachusetts, United States.

What does Eloxx Pharmaceuticals do?

Eloxx Pharmaceuticals, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Eloxx Pharmaceuticals a public company?

Yes. Eloxx Pharmaceuticals, Inc. trades on Nasdaq under the ticker ELOX.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences